pah

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

PAH, Pulmonary Hypertension, Hypertension Trial in Worldwide (Ralinepag, Placebo)

Recruiting
  • PAH
  • +10 more
  • Tucson, Arizona
  • +36 more
Jan 27, 2023

PAH Trial in Worldwide (sotatercept)

Recruiting
  • Pulmonary Arterial Hypertension
  • PAH
  • Sotatercept
  • Phoenix, Arizona
  • +167 more
Jan 27, 2023

PAH Trial in United Kingdom, United States (CXA-10)

Terminated
  • PAH
  • Birmingham, Alabama
  • +36 more
Aug 24, 2020

PAH Trial in United Kingdom, United States (75mg CXA-10, 150mg CXA-10, Placebo)

Terminated
  • PAH
  • 75mg CXA-10
  • +2 more
  • Birmingham, Alabama
  • +45 more
Aug 6, 2020

Implantable Medication Pump for Intravenous Treprostinil Therapy

Unknown status
  • Pulmonary Arterial Hypertension
  • PAH
  • Treprostinil via implanted pump
  • Berlin, Germany
  • +7 more
Mar 12, 2020

PAH Trial in United States (oral treprostinil)

Completed
  • PAH
  • oral treprostinil
  • Palo Alto, California
  • +8 more
Dec 12, 2018

PAH Trial in Austin (TransCon PEG treprostinil)

Withdrawn
  • PAH
  • TransCon PEG treprostinil
  • Austin, Texas
    PPD Development
Aug 6, 2014

Pulmonary Arterial Hypertension Treated With Nilotinib

Withdrawn
  • PAH
    • Cleveland, Ohio
      Cleveland Clinic
    Feb 3, 2014

    Pulmonary Hypertension and Imatinib

    Completed
    • PAH
      • Aurora, Colorado
      • +7 more
      Feb 3, 2014